• Company Presentation October 2018
• Kiadis Pharma launches a private placement of approximately 2.25 million new shares
  • Kiadis Pharma launches a private placement of approximately 2.25 million new shares
• Kiadis Pharma launches a private placement of approximately 3.7 million new shares Overview
  • Kiadis Pharma launches a private placement of approximately 3.7 million new shares
• Kiadis Pharma raises €18.0 million in a private placement of 2.25 million new shares
  • Kiadis Pharma raises €18.0 million in a private placement of 2.25 million new shares
• Kiadis Pharma raises €23.4 million in private placement overview
  • Kiadis Pharma raises €23.4 million in private placement
• Kiadis Pharma raises €31.2 million in a private placement of 3.9 million new shares overview
  • Kiadis Pharma raises €31.2 million in a private placement of 3.9 million new shares
• Private Placement Overview
  • Private Placement
• Private Placement Overview March 2018
  • Private Placement March 12, 2018
• Registration Document Overview March 2018
  • Registration Document March 2018
• Summary and Securities Note Overview
  • Summary and Securities Note
• Technician Bioassays Analytical Development
• Webcast Key Opinion Leader Meeting 22 May 2017 – New York City
• Home Page
• Overview of Diseases
• Overview of Products & Technology
• Investors
  • Corporate Governance
  • Financial Reports and Presentations
  • Regulatory News
  • Shareholders’ Meetings
  • Stock Information
  • Major shareholders
• Kiadis Pharma Launches its Initial Public Offering and Listing on Euronext Amsterdam and Euronext Brussels
• For Healthcare Professionals
• Company Overview
  • Management Team
  • Supervisory Board
  • Partners and Advisors
• News & Events
  • Events
    • Event Archive
  • In the Media
  • News
• Contact
• Legal disclaimer
• Cookies
• Privacy
• Sitemap